These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34976930)

  • 1. SARS-CoV-2 Transmissibility Within Day Care Centers-Study Protocol of a Prospective Analysis of Outbreaks in Germany.
    Schienkiewitz A; Jordan S; Hornbacher A; Perlitz H; Zeisler ML; Sandoni A; Kubisch U; Wess B; Kuttig T; Schaffrath-Rosario A; Damerow S; Rattay P; Varnaccia G; Loer AM; Wormsbächer J; Cohrdes C; Wetzstein M; Albrecht S; Hey I; Michel J; Schrick L; Gößwald A; Allen J; Schlaud M; Busch MA; Butschalowsky H; Wernitz J; Otte Im Kampe E; Buchholz U; Haas W; Schaade L; Wieler LH; Ziese T; Lampert T; Loss J
    Front Public Health; 2021; 9():773850. PubMed ID: 34976930
    [No Abstract]   [Full Text] [Related]  

  • 2. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
    de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
    JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Testing for Respiratory and Gastrointestinal Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Day Care Centers in Hesse, Germany.
    Hoehl S; Kreutzer E; Schenk B; Westhaus S; Foppa I; Herrmann E; Ettrich I; Leondaraki M; Schaible A; Rudych O; Rabenau H; Berger A; Ciesek S
    Clin Infect Dis; 2021 Nov; 73(9):e3036-e3041. PubMed ID: 33388748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020.
    Grijalva CG; Rolfes MA; Zhu Y; McLean HQ; Hanson KE; Belongia EA; Halasa NB; Kim A; Reed C; Fry AM; Talbot HK
    MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(44):1631-1634. PubMed ID: 33151916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Transmission of SARS-CoV-2 in US Child Care Centers After COVID-19 Vaccines.
    Shope TR; Chedid K; Hashikawa AN; Martin ET; Sieber MA; Des Ruisseau G; Williams JV; Wheeler SE; Johnson M; Stiegler M; D'Agostino H; Balasubramani GK; Yahner KA; Wang-Erickson AF
    JAMA Netw Open; 2023 Oct; 6(10):e2339355. PubMed ID: 37874566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of shedding and household transmission of severe acute respiratory syndrome coronavirus 2 using intensive high-resolution sampling.
    Altamirano J; Govindarajan P; Blomkalns AL; Leary S; Robinson I; Chun LX; Shaikh NJ; Robinson ML; Lopez M; Tam GK; Carrington YJ; De Araujo MB; Walter KS; Andrews JR; Burns J; Hogan C; Pinsky BA; Maldonado Y
    PLoS One; 2024; 19(7):e0305300. PubMed ID: 39052659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial.
    Forster J; Streng A; Rudolph P; Rücker V; Wallstabe J; Timme S; Pietsch F; Hartmann K; Krauthausen M; Schmidt J; Ludwig T; Gierszewski D; Jans T; Engels G; Weißbrich B; Romanos M; Dölken L; Heuschmann P; Härtel C; Gágyor I; Figge MT; Kurzai O; Liese J;
    JAMA Netw Open; 2022 Jan; 5(1):e2142057. PubMed ID: 34982157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission Rates Detected by Dense Saliva Sampling.
    Kolodziej LM; van Lelyveld SFL; Haverkort ME; Mariman R; Sluiter-Post JGC; Badoux P; de Koff EM; Koole JCD; Miellet WR; Swart AN; Coipan EC; Meijer A; Sanders EAM; Trzciński K; Euser SM; Eggink D; van Houten MA
    Clin Infect Dis; 2022 Aug; 75(1):e10-e19. PubMed ID: 35385575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
    Bhatt M; Plint AC; Tang K; Malley R; Huy AP; McGahern C; Dawson J; Pelchat M; Dawson L; Varshney T; Arnold C; Galipeau Y; Austin M; Thampi N; Alnaji F; Langlois MA; Zemek RL
    CMAJ Open; 2022; 10(2):E357-E366. PubMed ID: 35414597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 16. [SARS-CoV-2 incidence, transmission, and containment measures in daycare centers during the COVID-19 pandemic-findings from the Corona Daycare Study].
    Loss J; Kuger S; Buchholz U; Lehfeld AS; Varnaccia G; Haas W; Jordan S; Kalicki B; Schienkiewitz A; Rauschenbach T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Dec; 64(12):1581-1591. PubMed ID: 34731294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.
    Li F; Li YY; Liu MJ; Fang LQ; Dean NE; Wong GWK; Yang XB; Longini I; Halloran ME; Wang HJ; Liu PL; Pang YH; Yan YQ; Liu S; Xia W; Lu XX; Liu Q; Yang Y; Xu SQ
    Lancet Infect Dis; 2021 May; 21(5):617-628. PubMed ID: 33476567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Transmission of Severe Acute Respiratory Syndrome Coronavirus Type 2 in Childcare Facilities: A Longitudinal Study.
    Haag L; Blankenburg J; Unrath M; Grabietz J; Kahre E; Galow L; Schneider J; Dalpke AH; Lück C; Büttner L; Berner R; Armann JP
    J Pediatr; 2021 Oct; 237():136-142. PubMed ID: 34324882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.